Clearly Hormonal

Komal Patil-Sisodia, MD

Have you ever wondered why your body feels like it's falling apart just as you're hitting your stride in other areas of your life? Join Dr. Komal Patil-Sisodia as she explores women’s metabolic health changes that start in perimenopause. The episodes center around educating and empowering women to have open dialogue with their doctors so that they can achieve their best metabolic health. Dr. Patil-Sisodia is board certified in Endocrinology,  Obesity Medicine and Internal Medicine. She is also a Menopause Society Certified Practitioner. Any medical discussion on this podcast is purely for educational purposes and is not individualized medical advice. Please consult with your doctor to discuss any health concerns you may have.

  1. 20h ago

    The Peptide Vote: What the FDA's Advisors Just Recommended

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Dr. Komal Patil-Sisodia explains that headlines claiming “FDA approves peptides” are misleading: an FDA advisory committee narrowly voted to recommend adding six peptides (BPC-157, TB-500, KPV, MOTS-c, Epitalon, Semax) to a compounding list, a step that is not FDA approval and still faces a formal FDA process. She notes FDA scientists opposed adding all six and that some voting members sell these peptides. Reviewing the evidence, she explains that BPC-157 has only three small, weak human studies; TB-500 has zero human trials for the injury uses it's marketed for (while full thymosin beta-4 has some real human data); KPV has no human studies at all; MOTS-c has an unpublished Phase 1b trial and only observational, exercise-related human data; Epitalon lacks Western peer-reviewed human trials; and Semax is approved in Russia but with limited-quality stroke data. She emphasizes that all six are synthetic despite being marketed as "natural," that marketing to midlife women is running well ahead of the evidence, that contamination and mislabeled dosing have been documented in online peptide products, that compounded drugs bypass typical FDA review, and that proven options already exist for symptoms like hot flashes, bone loss, and metabolic changes. Time Stamps: 00:00  Welcome to Clearly Hormonal 01:03  The FDA Vote Explained 03:09  BPC-157 Evidence Check 04:31  TB-500 vs. Thymosin Beta-4 06:01  KPV and Animal Data Limits 07:25  MOTS-c, Epitalon, Semax 11:32  Midlife Marketing Reality 13:37  What the List Means 14:23  Safety and Contamination Risks 16:06  Bottom Line and Next Steps 17:31  Wrap Up and Where to Follow Resources & Mentions Follow Dr. Patil-Sisodia on Instagram and TikTok: @drpatilsisodiaJAMA: “Under FDA, Unapproved Peptides Likely to Become More Widely Available” (Rita Rubin, MA, 2026)ABC News: “FDA advisers narrowly vote to add 6 peptides to a drug compounding list. What's next?” (July 24, 2026)Talanta (2018): impurity analysis of falsified peptide drugs seized from online pharmaciesExpert Opinion on Drug Safety (2026): FAERS pharmacovigilance study on compounded GLP-1 receptor agonistsJournal of Cellular and Molecular Medicine (2021): Phase I dose-escalation trial of recombinant human thymosin beta-4Zhurnal Nevrologii I Psikhiatrii (2018): Semax post-stroke rehabilitation studyThanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  2. Jul 22

    The Biggest Myths About Type 1 Diabetes (and the Truth Behind Them)

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Type 1 diabetes isn't just a childhood disease, and it isn't caused by sugar, weight, or lifestyle. In this episode, Dr. Komal Patil-Sisodia breaks down why type 1 diabetes is so often missed in adults, especially in people mislabeled as type 2, and introduces LADA (latent autoimmune diabetes in adults), a slow-moving form of type 1 that may account for up to a quarter of adult diagnoses. She walks through the clues that should prompt testing, the two blood tests that can change a diagnosis, and how perimenopause and menopause complicate blood sugar control for women living with type 1. The episode also covers pregnancy planning, the real (and often overstated) genetic risk to children, the underappreciated heart disease risk in women with type 1, and why needing insulin is never a sign of failure. In This Episode Why type 1 diabetes has nothing to do with sugar, weight, or lifestyleHow adult-onset type 1 gets misdiagnosed as type 2, and whyLADA (type 1.5): what it is and why it hides in plain sightThe clues that should prompt a GAD antibody and C-peptide testHow perimenopause and menopause make blood sugar harder to controlPregnancy with type 1 diabetes: what's actually trueThe real genetic risk to children (it's lower than you think)Why heart disease risk is elevated and underdiscussed in women with type 1Why insulin is not a “last resort” and never a sign you did something wrongThe technology (CGMs and automated insulin delivery) changing type 1 care Timestamps: 00:00   Why Type 1 Gets Missed 00:30   A Misdiagnosed Patient Story 02:52   Myth: Sugar Causes Type 1 05:31   Myth: Only Kids Get It 06:29   Adult Onset and the Honeymoon Period 08:41   LADA (Type 1.5) Explained 10:13   Perimenopause Makes It Harder 11:53   When to Test for Type 1 14:34   Pregnancy Myths and Facts 16:41   Heart Risk in Women 18:24   Insulin Shame and Stigma 20:44   Tech That Changed Diabetes Care 22:01   Perimenopause Management Tips 22:49   Key Takeaways and Next Steps 25:14   Final Thoughts and Share Resources Mentioned: GAD antibody test (glutamic acid decarboxylase antibody): the key immune marker for LADAC-peptide test: measures how much insulin your body is still producing on its ownContinuous glucose monitors (CGMs) and automated insulin delivery systemsMaternal-fetal medicine (perinatology) preconception counseling for planned pregnancies Disclaimer:  This podcast is for education, not personalized medical advice. Please discuss anything that resonates with your own healthcare team. Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  3. Jul 15

    Type 2 Diabetes Isn't a Moral Failing: Genetics, Hormones, Stigma, and the Truth About Insulin

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Type 2 Diabetes Isn't a Moral Failing: Genetics, Hormones, Stigma, and the Truth About Insulin If you've ever been told — or told yourself — that your type 2 diabetes is something you caused and something you could fix if you just tried a little harder, this episode is for you. Dr. Komal Patil-Sisodia spends 17 years of clinical experience (and personal family history) dismantling one of the most damaging narratives in medicine: that type 2 diabetes is a lifestyle disease you can will your way out of. In reality, it's a complex, progressive metabolic condition shaped by genetics, hormones, sleep, stress, and — for women specifically — perimenopause and menopause. This episode covers the real biology behind insulin resistance and beta-cell decline, why stigma is measurably making patient outcomes worse, why so many people misunderstand what insulin actually does, and why "remission" — not "reversal" — is the accurate, honest term for what's possible. In this episode: 00:00 — Welcome and Mission Introduction to Clearly Hormonal and why this particular episode is personal.01:00 — Diabetes Myths and Stigma The core myth — that diabetes is caused by bad choices and reversible through willpower — and the data on how stigma affects A1C, depression, and self-care engagement.03:18 — A Patient Story: A Midlife Shift A composite patient story of someone doing everything "right" whose A1C climbs anyway once perimenopause hits.04:15 — What Type 2 Diabetes Actually Is Insulin resistance, beta-cell decline, and why genetics account for 40–80% of risk.05:31 — Hormones, Sleep, and PMOS Estrogen as an insulin sensitizer, cortisol and chronic stress, the impact of poor sleep, and PMOS (formerly PCOS) as a major independent risk factor.08:52 — Type 1 vs. Type 2 Clarifier A quick, important distinction — type 1 diabetes is autoimmune and not the topic of this episode.09:15 — CGMs and the "I Can Feel It" Myth Why 64% of patients believe they can feel high blood sugar — and the story of using a CGM to show her dad he couldn't.12:48 — Insulin Fear and Complications Why so many patients believe insulin causes kidney damage, blindness, or amputations — and what actually causes those complications.15:07 — Diet Myths and Shame Vegetarian diets, "only sugar counts," and how internalized shame changes patient behavior.17:32 — Remission, Not Reversal The real data on remission rates over time, and why relapse is disease progression, not failure.19:59 — What Patients Deserve A call for full access to treatment — metformin, GLP-1s, SGLT2 inhibitors, insulin — without having to "earn" it first.22:38 — Menopause and the Diabetes Care Gap Why standard diabetes care ignores perimenopause and menopause, and what should be asked instead.23:48 — Key Takeaways and Share A recap and an invitation to pass this along to anyone who's been made to feel like their diabetes is their fault.Resources & Mentions: Continuous glucose monitors (CGMs) as standard-of-care discussionPMOS (formerly known as PCOS)Type 2 diabetes remission criteria (A1C 6.5% for 3+ months without medication)Disclaimer: This podcast is for educational purposes only and is not personalized medical advice. Please discuss anything you hear here with your own healthcare team. Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  4. Jul 8

    Thyroid Myth Busting (Part 2): What Actually Helps and What Doesn't

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Getting diagnosed with Hashimoto's can feel overwhelming, especially after spending five minutes online. Suddenly you're told to eliminate gluten, avoid broccoli, stop eating soy, buy expensive supplements, and ask your doctor for desiccated thyroid. But how much of that advice is actually supported by evidence? In Part 2 of the Thyroid Myth Busting series, endocrinologist Dr. Komal Patil-Sisodia separates fact from fiction using current medical research. You'll learn:  Why cruciferous vegetables are not harming your thyroid  When soy actually matters (hint: it's about medication timing)  Who should—and shouldn't—consider a gluten-free diet  Why iodine supplements can actually worsen thyroid disease  Which thyroid supplements have evidence (and which don't)  The truth about desiccated thyroid versus levothyroxine If you've ever felt overwhelmed by thyroid advice on social media, this episode is your evidence-based guide. Timestamps 00:00 Welcome to Clearly Hormonal 01:03 Why thyroid wellness advice can become overwhelming 02:04 Cruciferous vegetables, iodine, and what actually affects thyroid function 05:03 Soy consumption and levothyroxine timing 06:16 Hashimoto's, gluten, and when celiac testing matters 09:35 The dangers of iodine supplements and seaweed products 13:08 Fact-checking popular thyroid supplements:  Ashwagandha  Vitamin B12  Low-dose naltrexone (LDN)  Selenium 17:05 Desiccated thyroid vs levothyroxine: What the evidence says 23:05 Key takeaways and what's next Resources & Links: Catch up on Part 1 (testing myths, TSH, subclinical hypothyroidism)Follow @drpatilsisodia on Instagram and TikTokDisclaimer: This podcast is for education, not personalized medical advice. Talk to your own healthcare team about what's right for you. Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  5. Jul 1

    Think It's Your Thyroid? Midlife Fatigue, Weight Gain, and the Myths Behind "Normal" Labs

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. One in four women will have some degree of thyroid dysfunction after menopause — so it's not unreasonable to test it. But Dr. Komal Patil-Sisodia says the real problem isn't whether we test, it's what we do (or don't do) after the results come back "normal." In this episode, she breaks down the most common thyroid myths she hears in clinic: that fatigue and weight gain automatically mean thyroid disease, that everyone needs a full thyroid panel, and that a slightly elevated TSH always means you need medication. She walks through what TSH actually measures, when free T4 and T3 testing adds value, why antibody testing isn't a default screen, and the real risks of over-treating with levothyroxine. Then she dives into the part almost no one explains: how perimenopause and menopause change the way we interpret thyroid labs, why your TSH reference range shifts with age, and how starting estrogen therapy can change your thyroid medication needs. Timestamps 00:00 — Welcome to Clearly Hormonal01:03 — Is It Really Thyroid?02:27 — Myth 1: Symptoms Automatically Equal Thyroid Disease05:22 — Myth 2: Everyone Needs a Full Thyroid Panel06:04 How TSH Testing Works11:18 — When Extra Testing Actually Matters (pituitary, pregnancy, illness, med changes)18:32 — Thyroid Antibodies: What They Are and When to Check Them19:45 — Myth 3: Subclinical Hypothyroidism Always Needs Treatment23:07 — The Real Risks of Overtreatment (and What the Evidence Shows)26:56 — The Menopause–Thyroid Overlap No One Explains30:51 — How Estrogen Therapy Changes Your Thyroid Labs33:37 — Questions to Ask Your Doctor35:21 — Next Episode Preview & Wrap-UpResources & Studies Mentioned 2017 TRUST Trial (New England Journal of Medicine) — levothyroxine vs. placebo in adults 65+2025 Annals of Internal Medicine analysis of NHANES data on age/sex/race-specific TSH ranges2026 Hong Kong population study on age- and sex-specific TSH reference rangesKorean cohort study of 50,000+ women on thyroid dysfunction across the menopause transitionJAMA study on successful levothyroxine discontinuation in older adults on low-dose therapyConnect Instagram & TikTok: @drpatilsisodiaPodcast: Clearly HormonalPractice: eastsidemm.comIf this episode resonated, share it with a woman in your life who’s been searching for answers. Leave a review so more women can find this podcast.Disclaimer: This podcast is for educational purposes only and is not a substitute for personalized medical advice. Please discuss your own labs and symptoms with your healthcare team. Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  6. Jun 24

    Spit Happens: The Truth About Cortisol Testing

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Picture three women. One is spitting into four little tubes throughout the day, mailing them off to a lab, hoping to finally get answers about her "adrenal fatigue." Another has been on a steroid inhaler for years, or just got a cortisone shot in her knee, and has never once had her adrenal glands checked — even though statistically, she has roughly a coin-flip's odds of an abnormal result if anyone bothered to look. And a third, in her late forties, is being told her exhaustion and brain fog are adrenal fatigue, when what she actually needs is a conversation about perimenopause. Same hormone. Same small gland sitting on top of each kidney. Three completely different ways we get this wrong — and in this episode, Dr. Patil-Sisodia untangles all three. She starts with the myth: why multi-sample "adrenal fatigue" saliva and urine kits run on real, legitimate lab technology in service of a diagnosis that doesn't medically exist — and why that combination is exactly what makes them so convincing. Then comes the plot twist she didn't expect to be making: that same multi-sample saliva format is actually a gold-standard tool, just for something else entirely — screening for Cushing's syndrome, when cortisol runs too high instead of too low. From there, she walks through the tests that genuinely work for Cushing's, the pseudo-Cushing's patterns (depression, alcohol use, obesity, PCOS/PMOS, illness, and more) that can mimic it on paper, and the condition she says gets missed more than any other: steroid-related adrenal insufficiency, which affects about half of long-term steroid users — inhalers, creams, sprays, and injections included — while fewer than 1% are ever tested for it. The episode closes on something close to home for this show's listeners: how easily perimenopause gets relabeled as adrenal fatigue, what that mislabeling actually costs women, and three simple questions you can run any cortisol test through before you trust it. Time Stamps: [00:00]  Medicine Gets Cortisol Wrong — the three-part setup: wrong tests, wrong people, and the people who need testing but never get it. [01:07]  Adrenal Fatigue Myth — why multi-sample saliva/urine kits use real lab technology to chase a diagnosis with no recognized normal range. [03:08]  Real Use for Saliva — the plot twist: late-night saliva testing is legitimate gold-standard science, just for a different question. [06:19]  Cushing Syndrome Basics — the three tests that actually work: late-night saliva, 24-hour urine cortisol, and overnight dexamethasone suppression. [07:34]  Pseudo Cushing Pitfalls — how depression, heavy alcohol use, obesity, poorly controlled diabetes, PCOS/PMOS, illness, pain, eating disorders, and intense exercise can mimic Cushing's without being it. [09:19]  Steroid Induced Adrenal Suppression — the condition affecting roughly half of long-term steroid users (inhalers, creams, sprays, injections, possibly Depo-Provera) while under 1% get tested. [12:57]  Menopause Misdiagnosed — why perimenopause symptoms get scooped up under the adrenal fatigue umbrella, and what the research does and doesn't show. [17:06]  Testing Adrenal Insufficiency — the real diagnostic pathway: tapering first, the 8–9 a.m. blood draw, and how to read the result range. [18:55]  Cosyntropin Test Myths — the standard 250-microgram test versus the unvalidated low-dose version some sources still promote. [21:06]  Recovery and Reassurance — why an abnormal cortisol number is far more common than a true adrenal crisis, and why recovery can take months to over a year. [22:21]  Three Questions for Testing — what to ask before trusting any cortisol test: proven diagnosis, meaningful timing, gold-standard validation. [24:19]  Final Takeaways and Outro. Key Takeaways "Adrenal fatigue" and "chronic stress" are not recognized medical diagnoses — there is no validated normal range for the multi-sample panels marketed to diagnose them.The same multi-sample saliva testing format is legitimate gold-standard science — when it's used correctly, at the right time of night, repeated 2–3 nights, to screen for Cushing's syndrome.About half of people on long-term steroids (any form — pills, inhalers, creams, sprays, injections) have some degree of adrenal insufficiency. Fewer than 1% are ever tested.Perimenopause symptoms (fatigue, brain fog, anxiety, low libido) overlap heavily with the symptoms marketed as "adrenal fatigue" — and that overlap can delay real menopause care.Before trusting a cortisol test: ask what it's proven to diagnose, whether the timing matches the question, and whether it's been validated against the gold standard. Resources & Links Follow Dr. Patil-Sisodia: @drpatilsisodia on Instagram and TikTokSend fan mail / episode questions via BuzzsproutCatch up on the related myth-busting episode referenced in this one (adrenal fatigue supplements)Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  7. Jun 17

    6 Adrenal Myths: Why “Adrenal Fatigue” Isn’t Real and What Actually Matters

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. “My adrenals are shot.” If you’ve said some version of that sentence this year, Dr. Komal Patil-Sisodia believes that you feel terrible—she just wants you to know that adrenal fatigue isn’t a real diagnosis, a lab value, or something your adrenal glands can actually do. In this myth-busting episode, she takes on six widely held beliefs about the adrenal glands: from the supplement industry built around a condition with no validated test, to when an adrenal tumor actually needs surgery, to who really needs Cushing syndrome screening, to how peri-operative steroid dosing has changed. She closes with the myth she considers most dangerous—that real adrenal insufficiency is easy to spot—and explains why it’s so often missed for years, sometimes until a life-threatening adrenal crisis forces the diagnosis. Timestamps 00:00:  Welcome to Clearly Hormonal 01:03:  Setting up the adrenal fatigue myth 02:17:  Myth #1: “Adrenal fatigue” isn’t a real diagnosis 04:47:  Myth #2: Are adrenal support supplements safe and effective? 06:18:  Myth #3: Does every adrenal tumor need surgery? 07:57:  Myth #4: Should everyone with obesity or diabetes be screened for Cushing syndrome? 11:00:  Myth #5: Does everyone on chronic steroids need stress-dose steroids for procedures? 12:38:  Myth #6: Is adrenal insufficiency easy to diagnose clinically? 15:58:  Recap and what’s coming next Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

  8. Jun 10

    When the Room Goes Quiet: Scientific Integrity, Political Pressure, & What Was Lost at the ADA Conference

    📱 Send Us a Text Message! We’d love to hear from you! Please include your name and email address so we can reply. Don’t worry — this won’t sign you up for our email list. We’ll only use your info to respond to your question. Dr. Komal Patil-Sisodia records live from her hotel room on the final night of the ADA 86th Annual Scientific Sessions in New Orleans — still processing what she witnessed earlier that week. The NIH director didn't show up to his own keynote. A substitute speaker framed diabetes research under the MAHA agenda. And five physicians were escorted out of the conference by security for handing out a peer-reviewed article published in the ADA's own journal. This episode is her unfiltered account of what happened, what the science actually says, and why none of us — patients, clinicians, or researchers — can afford to let it quietly recede. In this episode: What the Kahn et al. Diabetes Care editorial actually arguesWhy an 89% drop in NIH funding notices is more alarming than it soundsHow a new policy is draining the research pipeline without a single congressional voteThe landmark diabetes trials — DPP, DCCT, TrialNet — that exist because of the infrastructure now being guttedA frank assessment of the ADA's official statementWhy diverse, long-horizon NIH research is existential for underserved populationsConcrete actions for patients, clinicians, researchers, and the communityTimestamps: 00:00 Welcome to Clearly Hormonal 01:03 Why This Episode Now 01:38 My Diabetes Roots 02:32 Keynote Cancellation Shock 03:46 Editorial Handout Incident 04:59 Inside the Kahn Editorial 06:13 Funding Collapse Explained 07:57 Oversight Councils Undermined 09:02 Policy Loophole Chokes Grants 10:24 Why NIH Research Matters 11:40 Why I Stayed 13:44 What the Keynote Said 15:35 The Core Contradiction 17:49 ADA Statement Breakdown 21:22 Who Gets Hurt Most 23:55 What We Can Do Next 25:56 Closing and Resources Resources mentioned: Kahn et al. Diabetes Care editorial (2026)ADA contact and advocacy toolsCongressional representative lookupHouse of Representatives lookupSTAT News coverage of the conferenceFind Dr. Patil-Sisodia: Instagram & TikTok: @drpatilsisodiaEastside Menopause & MetabolismClearly Hormonal is for educational purposes only and does not constitute personalized medical advice. Please discuss your individual health concerns with your own healthcare provider. Thanks for listening. Find more info about Clearly Hormonal on the website or Instagram.

5
out of 5
28 Ratings

About

Have you ever wondered why your body feels like it's falling apart just as you're hitting your stride in other areas of your life? Join Dr. Komal Patil-Sisodia as she explores women’s metabolic health changes that start in perimenopause. The episodes center around educating and empowering women to have open dialogue with their doctors so that they can achieve their best metabolic health. Dr. Patil-Sisodia is board certified in Endocrinology,  Obesity Medicine and Internal Medicine. She is also a Menopause Society Certified Practitioner. Any medical discussion on this podcast is purely for educational purposes and is not individualized medical advice. Please consult with your doctor to discuss any health concerns you may have.